NCT00257920View on ClinicalTrials.gov

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2008

Conditions
Chronic Kidney Disease, Stage 5Secondary Hyperparathyroidism
Interventions
DRUG

Zemplar® injection

6 mcg QOD

DRUG

Hectorol® injection

3.6 mcg QOD

Trial Locations (2)

68123

Bellevue

68131

Omaha

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00257920 - A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter